Home » Conferences & Events » Health Care » Reimbursement and Health Policy

Reimbursement and Health Policy

The Reimbursement Landscape for Novel Diagnostics: Current Limitations.
January 6, 2011

Personalized medicine has the potential to revolutionize patient care. The fundamental goal in...

BioBytes: The Biotech Drug Delivery Timeline
June 23, 2010

Biotech research holds a great deal of promise for future innovation in the treatment of...

Healing, Fueling, Feeding: How Biotechnology Is Enriching Your Life.
May 1, 2010

Biotechnology is all around us and is already a big part of our lives, providing breakthrough...

BioBytes: What are biosimilars?
January 20, 2010

Biosimilars, also known as follow-on biologics, may eventually expand access and provide...

More Articles →

Letters, Testimony & Comments

Alzheimer’s Disease: BIO's Comments on the Draft Framework for the National Plan to Address Alzheimer’s Disease
February 8 2012
Re:    Draft Framework for the National Plan to Address Alzheimer's Disease Dear Ms. Glied:     ...
Essential Health Benefit: BIO's Comments on the HHS Pre-rule Bulletin
January 31 2012
The Biotechnology Industry Organization (BIO) is pleased to submit the following comments on the Department of Health and Human Services...
BIO Comments on CMS Proposed Methodology for 2013 Star Ratings for Medicare Advantage and Prescription Drug Plans
January 20 2012
Re: Request for Comments Regarding Enhancements to the Part C and Part D Plan Ratings The Biotechnology Industry Organization (BIO)...
Coverage with Evidence Development: BIO's Comments on the Centers for Medicare and Medicaid Services’ (CMS) public solicitation for comments on Coverage with Evidence Development (CED)
January 20 2012
Re:      CED Public Solicitation Dear Dr. Jacques:           ...
Potential NCD Topics: BIO's Comments
November 23 2011
Dear Administrator Berwick: The Biotechnology Industry Organization (BIO) appreciates this opportunity to comment on the Centers for...
More Letters, Testimony & Comments →

Press Releases

BIO Announces Policy Panel Keynote Session for 2011 BIO International Convention
April 19 2011
WASHINGTON, D.C. (April 19, 2011) - Democratic and Republican party leaders and strategists will share their...
The Future of Healthcare Policy to be Plenary Discussion at 13th Annual BIO CEO & Investor Conference
February 9 2011
WASHINGTON, D.C. (Wednesday, February 09, 2011) -The Biotechnology Industry Organization (BIO) today announced that...
Challenges in Reimbursement Hamper Development of Novel Diagnostics
January 6 2011
WASHINGTON, D.C. (Thursday, January 06, 2011) - The Biotechnology Industry Organization (BIO) released today a report...
Media Registration for the 2011 BIO International Convention Now Available Online
January 3 2011
WASHINGTON, D.C. (Monday, January 03, 2011) - The Biotechnology Industry Organization (BIO) announced today that...
BIO Announces Initial Selection of Life Sciences Companies to Present at the 13th Annual BIO CEO & Investor Conference
December 13 2010
WASHINGTON, D.C. (Monday, December 13, 2010) - The Biotechnology Industry Organization (BIO) today announced the...
More Press Releases →